Assays of phosphoglycerate mutase (PGAM) activity in lysates of bloodstream form Trypanosoma brucei appeared not to require exogenous 2,3-bisphosphoglycerate, thus suggesting that this protist contains an enzyme belonging to the class of cofactor-independent PGAMs. A gene encoding a polypeptide with motifs characteristic for this class of enzymes was cloned. The predicted T. brucei PGAM polypeptide contains 549 amino acids, with M r 60 557 and pI 5.5. Comparison with 15 cofactor-independent PGAM sequences available in databases showed that the amino-acid sequence of the trypanosome enzyme has 59±62% identity with plant PGAMs and 29±35% with eubacterial enzymes. A low 28% identity was observed with the only available invertebrate sequence. The trypanosome enzyme has been expressed in Escherichia coli, purified to homogeneity and subjected to preliminary kinetic analysis. Previous studies have shown that cofactor-dependent and -independent PGAMs are not homologous. It has been inferred that the cofactor-independent PGAMs are in fact homologous to a family of metalloenzymes containing alkaline phosphatases and sulphatases. Prediction of the secondary structure of T. brucei PGAM and threading the sequence into the known crystal structure of E. coli alkaline phosphatase (AP) confirmed this homology, despite the very low sequence identity. Generally, a good match between predicted (PGAM) and actual (AP) secondary structure elements was observed. In contrast to trypanosomes, glycolysis in all vertebrates involves a cofactor-dependent PGAM. The presence of distinct nonhomologous PGAMs in the parasite and its human host offers great potential for the design of selective inhibitors which could form leads for new trypanocidal drugs.
Phosphoglycerate mutase (PGAM; EC 5.4.2.1) is an enzyme of the glycolytic and gluconeogenic pathways that catalyzes the interconversion of 2-and 3-phosphoglycerates. Two types of PGAMs can be distinguished. One type requires 2,3-bisphosphoglycerate as cofactor, whereas the other does not (reviewed in [1, 2] ). The cofactor-dependent enzyme (d-PGAM) is present in all vertebrates, the cofactor-independent one (i-PGAM) in all plants. In representatives of other taxa (invertebrates, fungi, eubacteria, archaebacteria) either or both of the enzymes can be found [3±6] . Through genome projects, it was shown that genes for both PGAMs are simultaneously present in eubacteria such as Escherichia coli and Bacillus subtilis [7±9], although previously only 2,3-bisphosphoglycerate-dependent PGAM activity had been reported for the former organism [10] , and a cofactor-independent activity for the latter one [11] . Only a few protists belonging to the Chlorophyta and Phaeophyta have been characterized with respect to the nature of their PGAM activity, and appeared to be cofactor-dependent [12] .
The two types of PGAMs are kinetically and structurally distinct. Cofactor-dependent mutases from a variety of organisms have been extensively characterized by sequencing of genes, analysis of enzyme kinetics, mutagenesis experiments and crystallography. The d-PGAMs are active as either monomers, dimers or tetramers depending upon the organism from which the enzymes have been isolated. The subunit mass of these enzymes is about 27 000 Da. In particular, the structure and catalytic mechanism of the tetrameric enzyme from Saccharomyces cerevisiae has been studied in great detail [13±17] . Cofactor-dependent PGAM catalyzes the transfer of a phospho group between different carbon atoms of the substrate via the formation of a phosphohistidine intermediate. The 2,3-bisphosphoglycerate is required to donate a phospho group to an active-site histidine residue and therebỳ prime' the enzyme. From the availability of crystal structures it became apparent that d-PGAM is homologous to rat prostatic acid phosphatase and rat liver fructose-2,6-bisphosphatase. These enzymes share extensive structural sequence similarities, although their sequences are quite divergent [18, 19] . Strikingly, all three enzymes possess two active-site histidine residues, and operate through a phosphohistidine intermediate.
Information on i-PGAMs is rather sparse. All i-PGAMs characterized so far are monomers of M r 60 000 [2] . Their sequences show no apparent homology with those of d-PGAMs. No crystal structure is available as yet. The limited studies performed on the reaction mechanism of i-PGAMs demonstrated that the enzyme acts in a fundamentally different [14, 20, 21] . Catalysis by i-PGAM involves the intramolecular transfer of phospho groups, whereas the d-PGAM catalyzes the intermolecular shuttling of phospho groups between the substrate and the cofactor. Furthermore, all attempts to identify a phosphorylated intermediate of i-PGAM failed, although the participation of a short-lived phosphoenzyme remains possible. Indeed, studies with isotopically labelled substrates and analogues provided strong evidence for such a phosphoenzyme intermediate [13] . Originally, i-PGAMs have been classified in two groups: enzymes such as B. subtilis PGAM which depend on divalent cations, particularly manganese, for activity, and other enzymes, notably from plants, without such requirement. However, the claimed metal independence has been disputed [22] and should possibly be attributed to incomplete chelation of those ions from the enzyme preparation. Moreover, Gran Äa et al. [23] noticed that a constellation of residues involved in metal-ion binding in various alkaline phosphatases is conserved in maize i-PGAM. This therefore supports the suggestion for the involvement of metal ions in the catalytic mechanism as well as the notion that these enzymes belong to the same family. The supposed relationship between the enzymes received recent further support from a more detailed sequence comparison [24] .
Here we report the cloning and characterization of the PGAM gene of Trypanosoma brucei and a preliminary analysis of the recombinant enzyme. Trypanosomes are protozoan organisms living in the bloodstream of humans and various other mammals. These parasites are responsible for sleeping sickness, a serious, often fatal disease of man in sub-Saharan African countries and for which no adequate drug treatment is available [25] . The bloodstream form of T. brucei obtains its free energy solely from glycolysis. For that reason, and because of the peculiar organization of most of the parasite's glycolytic pathway inside peroxisome-like organelles called glycosomes [26±28], glycolysis is perceived as a valid and promising target for the design of new trypanocidal drugs [29, 30] . We show that the trypanosome PGAM belongs to the cofactor-independent group of mutases. This offers great potential for drug design, as the enzyme of the human host is a cofactordependent PGAM.
M A T E R I A L S A N D M E T H O D S

Organisms and cell fractionation
Bloodstream forms of T. brucei 427 were grown in rats and harvested as described [31] . Procyclic trypomastigotes (insect stage cells) were grown in SDM-79 medium at 27 8C [32] . Cell lysates for enzyme assays were prepared by addition of Triton X-100 (0.1%). Cell fractionation by differential centrifugation and isopycnic sucrose-gradient centrifugation were carried out essentially as described previously [33] . High-molecular mass DNA was isolated from trypanosomes as described by Van der Ploeg et al. [34] .
Cloning and sequence determination of the T. brucei PGAM gene
After establishing the possible presence of an i-PGAM in trypanosomes by activity assays using whole cell lysates, amplification was performed with the following primers: (a) sense 5 H -ATGGGYAACWSCGARGTNGGNCA-3 H , corresponding to the amino-acid motif MGNSEVGH conserved in many plant and bacterial i-PGAM sequences (residues 70±77 in H -CCGCCGTTSMAGAARWANGT-NACRTG-3 H , corresponding to the peptide HVT(F/Y)F(W/F) NGG (residues 358±366 in Fig. 1 ). The total volume of the amplification mixture was 50 mL containing 500 ng of genomic DNA, 1.0 mm of each primer, 200 mm each of the four deoxynucleotides, 2 U of Taq DNA polymerase with the corresponding buffer (Qiagen, Germany) and 5% dimethylsulfoxide. PCR was performed in a Hybaid Thermal Reactor (Hybaid, UK), using the following program: first 1 min 94 8C; 5 cycles: denaturation 1 min, 94 8C; annealing 1 min, 53 8C; extension 1 min, 72 8C; 25 cycles: 1 min, 94 8C; 1 min, 55 8C; 1 min, 72 8C; and a final incubation of 10 min at 72 8C. One of the three DNA fragments thus obtained, having the expected length of approximately 900 bp, was purified and cloned using plasmid pCR2.1-TOPO and the`TOPO TA Cloning Kit' of Invitrogen (USA). Upon sequencing, the clone appeared to have i-PGAM specific motifs. It was then used as a hybridization probe to screen a genomic library of T. brucei established in E. coli with the phage vector lGEM11 (Promega, USA) [35] . Plaques of positive clones were processed, the DNA was purified and an appropriate restriction fragment containing the PGAM gene was subcloned in the phagemid pZErO-2 (Invitrogen), resulting in plasmid pTbPGAM158.
DNA sequence determination was performed on both strands by the chain-termination method using the T7 DNA polymerase kit of Pharmacia Biotech (Sweden), with double-stranded DNA as template, [ Expression of recombinant T. brucei PGAM in E. coli and purification of the enzyme The complete T. brucei PGAM gene was amplified via PCR using two custom-synthesized oligonucleotides: (a) 5 H -GAAATTTTTGCATATGGCACTCACGC-3 H , containing an NdeI site (underlined) adjacent to a sequence corresponding to the 5 H end of the PGAM gene, and (b) 5 H -CGCATGTTG-GATCCCTACGC-3 H , complementary to the 3 H -terminal coding region of the gene, followed by a BamHl restriction site (underlined). The total volume of the amplification mixture was 50 mL containing 20 ng of plasmid pTbPGAM158, 1.0 mm of each primer, 200 mm each of the four deoxynucleotides, and 2 U of Vent DNA polymerase with the corresponding 1Â ThermoPol Reaction Buffer (New England Biolabs, USA). PCR was performed using the following program: first 1 min 95 8C; 30 cycles: 1 min 94 8C, 1 min 55 8C and 1 min 72 8C; and a final incubation of 10 min at 72 8C.
The amplified fragment was purified, and upon adding 3 H A-overhangs by using Taq DNA polymerase and dATP, ligated into pCR2.1-TOPO. After checking its sequence, the amplified PGAM gene was liberated from the recombinant plasmid by digestion with NdeI and BamHI and ligated in the expression vector pET28a (Novagen, USA). The E. coli BL21(DE3)pLysS strain which has the T7 RNA polymerase gene under the control of the lacUV5 promoter [36] was then transformed with the recombinant pET28a-TbPGAM plasmid. Cells harbouring the recombinant plasmid were grown at 30 8C in 200 mL of Luria±Bertani medium supplemented with 1 m sorbitol, 2.5 mm betaine (to give osmotic stress [37] ), 30 mg´mL 21 kanamycin and 25 mg´mL 21 chloramphenicol. Isopropyl thio-b-d-galactoside was added to a final concentration of 1 mm when the culture reached an D 600nm of approximately 0.6 to induce the expression of the protein and growth was continued overnight. Cells were collected by centrifugation (12 000 g, 10 min, 4 8C) and resupended in 10 mL of cell lysis buffer containing 50 mm triethanolamine/ HCl (pH 8.0), 200 mm KCl, 1 mm KH 2 PO 4 , 5 mm MgCl 2 , 10% glycerol, 0.5 mm Tris(2-carboxyethyl)phosphine/HCl (Pierce, USA) and a protease inhibitor mixture (Roche Molecular Biochemicals, Germany). Cells were lysed by two passages through a SLM-Aminco French pressure cell (SLM Instruments Inc., USA) at 90 Mpa. The lysate was centrifuged (12 000 g, 15 min, 4 8C) and PGAM in the soluble cell fraction was further purified. Nucleic acids were removed by treatment with 250 U Benzonase (Merck, Germany) for 30 min at 37 8C and protamine sulphate (0.5 mg´mL
21
) followed by centrifugation for 10 min at 12 000 g. The protein was further purified using immobilized metal affinity chromatography (TALON resin, Clontech, USA) exploiting the His 6 tag at the N-terminus of the protein. Elution was performed with lysis buffer containing 50 mm imidazole. A final purification step was performed by gel filtration using Sephacryl S-200 (Pharmacia Biotech). The purity of the protein was assessed by SDS/PAGE followed by Coomassie brilliant blue staining.
Enzyme assay, protein determination and electrophoresis
For routine assays, the PGAM activity was measured by coupling its reaction to lactate dehydrogenase via enolase and pyruvate kinase, and following the decrease of NADH absorbance at 340 nm using a Beckman DU7 spectrophotometer. The assay was performed at 25 8C in a 1.0-mL reaction mixture containing 0.1 m triethanolamine/HCl (pH 7.4), 5.0 mm 3-phosphoglycerate, 1.0 mm MgSO 4 , 1.0 mm ADP, 0.25 mm NADH and 0.1% Triton X-100. The auxiliary enzymes, lactate dehydrogenase, enolase and pyruvate kinase, were used at final activities of 1, 1 and 2 U´mL 21 , respectively. NADH, ADP, 3-phosphoglycerate, lactate dehydrogenase, enolase and pyruvate kinase were purchased from Roche Molecular Biochemicals. One activity unit is defined as the conversion of 1 mmol substrate´min 21 under these standard conditions.
The K m of T. brucei PGAM for 3-phosphoglycerate was determined at the above mentioned reaction conditions, by varying its concentration between 5 mm and 10 mm. To determine the enzyme's affinity for its substrate in the reverse reaction, the assays were performed in a reaction mixture containing 0.1 m triethanolamine/HCl (pH 7.4), 5.0 mm 2-phosphoglycerate, 5.0 mm MgSO 4 , 1.0 mm ATP (neutralized with equimolar quantities of NaHCO 3 ), 0.42 mm NADH, 1.0 mm dithiothreitol and as auxiliary enzymes glyceraldehyde-3-phosphate dehydrogenase and 3-phosphoglycerate kinase, both at final activities of 4 U´mL
21
. The K m for 2-phosphoglycerate was determined by varying its concentration between 10 mm and 10 mm. Values given for kinetic parameters are the means of data as calculated from Lineweaver±Burk, Hanes and Eadie±Hofstee plots, after optimal curve fitting of experimentally determined data, using the ultrafit Biosoft program for Macintosh.
Protein content was measured by the fluorescamine method [38] , using bovine serum albumin as standard. Sodium deoxycholate (0.2% final concentration) was added prior to the addition of other reactants.
Polyacrylamide gel electrophoresis in the presence of 0.1% SDS was performed according to Laemmli [39] .
Alignment of sequences, structure modelling and phylogenetic analysis
Several web-based programs were used to compare the sequence of T. brucei PGAM with sequences and structures in databases. The clearest results for structural similarity were obtained using the methods of Fischer and Eisenberg [40] . The greatest significance score was achieved using the Gonnet matrix and additional information derived from secondary structure prediction and multiple sequence alignment. This method produced a Z-score for T. brucei PGAM threaded into the E. coli alkaline phosphatase (AP) structure (1alk.pdb) of 8.16. This score is well above the confidence threshold provided by the authors of 5.0^1.0 and well-separated from the next highest scoring fold at 4.94. The alignment produced covered only the C-terminal half of trypanosome PGAM, but a related method, ignoring multiple sequence alignment information and run on the same server, again gave 1alk.pdb as the top hit, this time with an alignment covering all the T. brucei PGAM sequence. This was used to produce an initial alignment of groups of i-PGAMs and APs, previously individually aligned with clustal w [41] . Information from sequence comparisons within a superfamily of metalloenzymes including i-PGAMs and APs [24] was then used to make adjustments to the alignment. Further adjustments to the alignment were made to match the predicted secondary structure of trypanosome PGAM, calculated by the PHD program [42±44], to the actual Fig. 1 . Multiple alignment of the amino-acid sequences of five cofactor-independent phosphoglycerate mutases and two representative alkaline phosphatases. The T. brucei sequence was aligned with the 15 full-length i-PGAM sequences of other organisms available in databases, using the method described in Materials and methods. This figure shows 4 selected, representative i-PGAM sequences in addition to that of the trypanosome enzyme: Ricinus communalis (EMBL/GenBank/DDJB accession number X70652), Zea mays (M80912/Z33611), Bacillus subtilis (L29475/Z99121) and Escherichia coli (AE000439/U00039). Other sequences used in the master alignment are: Mesembryanthemum crystallinum (U16021), Nicotiana tabacum (X70651), Arabidopsis thaliana (AC000132), Mycoplasma genitalium (U39725), Mycoplasma pneumoniae (AE000021), Pseudomonas syringae (U12776), Helicobacter pylori (AE000606), Caenorhabditis elegans (AF039713), Synechocystis sp. (D90915), Porphyra purpurea (U38804) and Antithamnion sp. (X64705). The master alignment also contains 14 AP sequences, two of them are shown here: human placenta 1 (M13077) and E. coli (J01659). The Nterminal and C-terminal regions of the alignment, extending beyond the termini of the PGAM sequences, are not shown. Sequence numbering and annotation of secondary structure elements is according to the E. coli AP enzyme (ACTUAL 1alk SS) for which the crystal structure is known (1alk.pdb), and the secondary structure of T. brucei PGAM (PRED. TbPGAM SS), predicted as described in Materials and methods. The annotation is as follows: horizontal arrows above the alignment, b strands; cylinders, a helixes; positions showing complete sequence conservation in the PGAMs or APs are separately boxed; positions where at least 75% of all sequences, APs and PGAMs, share the same residue are emboldened; N, active-site nucleophile; P, phosphate-binding Arg residue; M, residues involved in magnesium binding; 1 and 2, residues of metal-binding sites 1 and 2; * residue 51 that participates in both the magnesium and metal site 2; filled triangles beneath the sequences indicate His residues that have been mutated in the R. communis PGAM, and the percentage of remaining activity, when the recombinant enzyme was not insoluble (insol), is given underneath. The full sequence alignment can be found on the internet (http://asparagin.cenargen.embrapa.br/,daniel/Public/tbpgam/). q FEBS 2000 secondary structure of 1alk.pdb, determined with the program DSSP [45] . The structural consequences of the alignment produced were visualized using the program o [46] . The alignment was graphically displayed using the alscript program [47] .
Pairwise distances between the sequences were calculated using the`Draw Tree' option of clustal w excluding regions with gaps. Phylogenetic analysis was performed after removal of the gaps using maximum likelihood (program puzzle [48] ), maximum parsimony (program protpars, phylip package) and distance methods (programs protdist and neighbor, phylip package; the phylogeny inference package phylip, version 3.5c, was distributed by J. Felsenstein, Department of Genetics, University of Washington, Seattle).
R E S U L T S A N D D I S C U S S I O N PGAM activity in T. brucei
Initial attempts to identify a d-PGAM gene in T. brucei by PCR amplification and by hybridization using the Schizosaccharomyces pombe PGAM gene as a probe (kindly provided by L. Gilmore, University of Edinburgh, UK) were unsuccessful. The nature of the trypanosome enzyme was therefore assessed by determining the requirement of the cofactor 2,3-bisphosphoglycerate in activity assays. Different dilutions of cell lysate were assayed for PGAM activity as described in Materials and methods, with and without 2,3-bisphosphoglycerate. No significant difference in reaction rate was observed over the 10-min assay period, even when the 2,3-bisphosphoglycerate concentration in the assay was increased to 0.60 mm. These results suggested to us that the trypanosome PGAM has no requirement for the cofactor.
Opperdoes and Borst [26] showed that in bloodstream form T. brucei the first seven enzymes of the glycolytic pathway, responsible for the conversion of glucose into 3-phosphoglycerate, are contained in glycosomes, whereas enolase and pyruvate kinase were found in the cytosol. No information was provided about PGAM, but Oduro et al. [49] could locate the enzyme in the cytosol. Indeed, we could confirm the cytosolic localization (not shown). However, only low specific activities of PGAM were found in cell lysates [approximately 10±25 nmol´min 21´( mg protein) 21 ], much lower than for any other glycolytic enzyme and inconsistent with the trypanosome's high glycolytic flux (80 nmol of glucose consumed per min per mg of protein). Oduro et al.
[49] also reported relatively low specific activity of PGAM, albeit somewhat higher than in our experiments and dependent on the cell disruption procedure. It has been reported that i-PGAM of wheat germ and Aspergillus nidulans is rapidly and irreversibly inactivated by metal-chelating agents such as EDTA [50] . As our trypanosome lysates are usually prepared in isotonic solutions containing EDTA (0.25 m sucrose, 25 mm Tris/HCl, pH 7.4, 1 mm EDTA), we examined the possibility that the low specific activity found in the lysates could be attributed to the action of the chelator. Higher specific activities [up to 200 nmol´min 21´( mg protein) 21 could indeed be observed in trypanosome extracts prepared in the absence of any chelator. The replacement of EDTA by EGTA in cell fractionation did not have any effect on the subcellular distribution of PGAM. In both bloodstream form and procyclic trypanosomes, essentially all activity was found in the highspeed supernatant fraction. In standard PGAM assays (see Materials and methods) using purified recombinant T. brucei enzyme (see below), addition of EDTA resulted in an instantaneous inhibition, with more than 80% decrease of the enzyme activity at a concentration of 1 mm, whereas EGTA even up to a concentration of 5 mm did not have any effect (not shown).
Cloning and sequence determination of the T. brucei PGAM gene
After having obtained indications for the existence of an i-PGAM in T. brucei, PCR amplification was performed using genomic DNA as template and degenerate oligonucleotides corresponding to conserved areas of plant and bacterial i-PGAM sequences as primers. A fragment of approximately 900 bp was thus obtained which after cloning and sequencing indeed appeared to contain i-PGAM specific motifs. The fragment was subsequently used to screen a genomic library by hybridization. A gene thus identified was sequenced, revealing the presence of an open-reading frame coding for a polypeptide of 549 amino acids (excluding the initiator methionine). The polypeptide has a calculated molecular mass of 60 557 Da, and a predicted pI of 5.5.
Southern blot analysis of genomic T. brucei DNA revealed a pattern of fragments compatible with a single gene for i-PGAM per haploid genome.
The structure of T. brucei PGAM
The amino-acid sequence of the trypanosome PGAM was assessed against a library of target structures using the proteinfold recognition method described by Fischer and Eisenberg [40] , to obtain information about its three-dimensional fold and the residues which may possibly be involved in substrate binding and the catalytic mechanism. By this threading method, the i-PGAM was recognized as an enzyme that is structurally similar to E. coli AP. The similarity is supported by a significance score (8.16) well above a confidence threshold (5.0), despite the very low sequence identity (22%) between the two polypeptides. No significant similarity scores were obtained with other protein structures in the database. This result confirms the earlier conclusions drawn from sequence comparison of maize i-PGAM and bacterial AP [23, 24] . In addition, the PHD program [42±44] was used to predict the secondary structure of the T. brucei i-PGAM. Figure 1 presents a structural alignment of the sequences of various i-PGAMs and APs, based on the structural information from E. coli AP and the structure prediction of trypanosome i-PGAM, and prepared as described in detail in the Materials and methods section. Generally a good match was observed between predicted and actual secondary structure elements. For example, the alignment shows conservation of all beta strands of the AP structure with the exception of one edge strand of the central 10-strand sheet and three strands forming a small separate sheet. However, the structural match is significantly worse in some areas so that large scale differences in parts of the structure cannot be ruled out. Despite this possibility, a number of inferences can be made about the structure of i-PGAM and the function of specific residues from the alignment, the structural fold of AP, the known role of certain amino acids in the binding of its substrate and its catalytic mechanism (Fig. 2) .
Three metal ions are involved in the catalysis by AP; two zinc ions and a magnesium ion. Biochemical data and current ideas about mechanism agree that the two zinc ions are essential while the contribution of the magnesium ion is small and indirect [51] . The two Zn 2+ -binding sites of AP are entirely conserved in PGAM. However, only some of the residues contributing to the Mg 2+ -binding site are found in PGAM: Asp51 in APs is conserved as Asp21 in PGAM, Ser/Thr155 is conserved as Ser135, but Glu322 is replaced by the invariant Asn418. This replacement, and the likely different positioning of AP Ser/Thr155 and PGAM Ser135, due to a nearby 2-residue deletion, suggest that the Mg 2+ -binding site is not present. The nucleophile of the APs, Ser102 is not conserved. The alignment shows a conserved Ser73 among the i-PGAMs but this may not be aligned with Ser102 as this leads to the burial of the conserved His77. If a hydroxyl nucleophile is found to be implicated in the mechanism of i-PGAMs then the conserved Ser135 of i-PGAMs (aligned with Ser/Thr155 of APs ± see above) would be a candidate. The separation of the hydroxyl groups of Ser102 and Thr155 in the E. coli AP crystal structure is just 4 A Ê and, as already noted, the 2-residue deletion near position 155 in the PGAMs means that its local conformation will be different. Thus, a Mg 2+ ligand in the APs may become the nucleophile in the i-PGAMs. The phosphate ligand of APs, Arg166, is not conserved but there are several other conserved Arg residues that might bind substrate (see below).
Mutation in Ricinus communis PGAM of three histidine residues leads to inactive enzyme [52] . They are residues 494, corresponding to AP His412, a ligand of one of the catalytic zinc atoms, 358 and 134. When a histidine residue is modelled at position 153 of the AP structure, corresponding to His134, the side chain is within hydrogen bonding distance (2.5 A Ê ) of the bound phosphate ion. When His358 is similarly modelled, the side chain is 7.5 A Ê from the phosphate, close enough to contribute to the catalytic site. Hence, all three of the presumed catalytically essential histidine residues are found near the active site of our PGAM model. The model also shows that residues conserved in APs and i-PGAMs are situated solely on one side of the active site. On the other side are clustered the unconserved active site residues (rendered black in Fig. 2 ; Arg166, Glu322, Ser102) and the residue`conserved' in sequence but probably not in function (rendered grey; Thr155). The loops C±D and F±G pass nearby this altered side of the active site. The lengths of both of these loops are different so that the overall shape of the active site will be different. A more defined binding pocket would be expected for PGAMs than the shallow depression seen in APs. In both loops, strongly conserved sequence motifs are seen within the PGAMs but not within the APs. For loop C±D there is an invariant stretch GGVHS containing His134 and Ser135 discussed above. For loop F-G there is a region ETxK(F/Y)xHVT (F/Y)F containing His358 discussed above. The sequence alignment (Fig. 1 ) reveals several conserved Arg residues The tree was constructed using the neighbour-joining method [54] . Maximum likelihood distances were calculated using the puzzle program, version 4.0.1 [48] , and the JTT model of amino-acid substitution [55] . Support values for internal branches were calculated using quartet puzzling [48] . If strands E and F are preserved in the same orientation then they cannot contribute to the active site. Arg200 is the best substrate-binding residue candidate. Access of Arg200 to the active site is blocked by the side chain of Glu149 in the APs but in the PGAMs this position is occupied by a glycine, and the backbone length is reduced by one residue in the PGAMs. These changes would remove any steric bar to the participation of Arg200 in the active site. Given the extra size of the D-E loop in PGAMs, Arg207 is also a likely substrate-binding residue.
Phylogenetic analysis of cofactor-independent phosphoglycerate mutases
The alignment of 16 available full-length i-PGAM amino-acid sequences was used for a phylogenetic analysis using the maximum-likelihood method (Fig. 3) . The trypanosome enzyme is most closely related to cytosolic plant i-PGAMs; it has 59±62% positional identity with the five available plant enzyme sequences, and shares specific insertions and deletions with them (Fig. 1) . The identity with seven eubacterial and two chloroplast sequences varies between 29 and 35%. A mere 28% identity was observed with the only available invertebrate (Caenorhabditis elegans) i-PGAM sequence. The close association of the T. brucei i-PGAM with the plant cytosolic sequences is supported by a high quartet puzzling value (99) and was also confirmed by both maximal-parsimony and neighbour-joining distance methods which gave the same branching order (not shown).
Recombinant PGAM of T. brucei : expression, purification and preliminary characterization T. brucei PGAM was expressed in E. coli cells as recombinant enzyme with a 20 residue extension including six His residues fused to its N-terminus. No high production levels were achieved, despite attempting many different growth conditions (different growth media, temperature, induction regimes, etc.). Optimal expression of active, soluble protein was obtained by growing and inducing the cells under osmotic stress in the presence of sorbitol and betaine as described [37] . Purification was performed in three steps: (a) elimination of the nucleic acids from the lysate (b) immobilized metal affinity chromatography exploiting the (His) 6 tag on the protein and (c) gel filtration, as described in detail in the section Materials and methods. PGAM could be purified 83.6-fold to homogeneity as assessed by SDS/PAGE, having a specific activity of 100.4 U´mg 21 , with a yield of 0.162 mg from a 200-mL culture of recombinant bacteria (Fig. 4 and Table 1 ).
The recombinant protein thus obtained has been subjected to a preliminary kinetic analysis. Under the conditions described above, the following values for the Michaelis constants were measured: for the forward reaction, the K m = 0.15^0.02 mm for the substrate 3-phosphoglycerate; for the reverse reaction, the K m = 0.16^0.03 mm for 2-phosphoglycerate. These affinities are within the same range as reported for i-PGAM from other organisms: 0.29±0.50 mm for 3-phosphoglycerate and 0.04±0.11 mm for 2-phosphoglycerate (1,20,52).
C O N C L U S I O N S
The T. brucei PGAM gene has been cloned and characterized. The trypanosome possesses a cofactor 2,3-bisphosphoglycerate independent PGAM. Cofactor-independent PGAMs are highly different from their cofactor-dependent counterparts. From comparisons of crystal structures it is known that the latter enzymes belong to the superfamily of acid phosphatases operating through a phosphohistidine intermediate. In this paper we provide further evidence by structure modelling that the i-PGAMs belong to the alkaline phosphatase superfamily. All vertebrates contain only d-PGAMs. The use of a different class of PGAM in the glycolytic pathway of the trypanosome and its human host offers great potential for the design of selective inhibitors which could form leads for new trypanocidal drugs.
T. brucei PGAM shares with plant and fungal i-PGAMs its susceptibility for metal-chelating agents. The presence of EDTA results in the irreversible inactivation of the trypanosome enzyme. This observation explains why previous assays of PGAM activity in lysates of T. brucei and other kinetoplastid protozoa prepared in the presence of the chelating agent revealed only low activities, at variance with the high glycolytic flux as measured in these organisms.
The T. brucei i-PGAM has been expressed in E. coli cells. Only low expression levels of soluble enzyme could be achieved. The bacterially expressed enzyme has been purified and subjected to a preliminary kinetic analysis. Affinity chromatography exploiting a His-tag fused to the N-terminus of the trypanosome PGAM facilitated the purification and excluded the possibility that the endogenous bacterial enzyme was isolated. The development of a heterologous expression system that provides higher yields of trypanosome i-PGAM will be necessary for our future detailed kinetic and structural studies of the enzyme for a structure-and/or catalytic mechanism-based drug design.
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